Myeloproliferative Neoplasms (MPN)

Fatigue, Symptom Burden and Health-Related Quality of Life Concerns

Thumbnail for video Register Now

Topic(s)
Aplastic Anemia
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Carmelita P. Escalante, M.D.

In this webinar, you will gain an understanding of symptom burden, recognizing how symptoms affect your daily activities, and exploring strategies to help manage fatigue and other challenges. Learn how to communicate your concerns with your healthcare team and take an active role…

Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study

Original Publication Date
Article Source
External Web Content
Relapse is the leading cause of allogeneic hematopoietic stem cell transplant (allo-HSCT) failure in myeloid neoplasms [1]. Patients receiving reduced-intensity conditioning (RIC) regimens have a higher risk of post-transplant relapse compared to those undergoing myeloablative…

Germline predisposition in myeloproliferative neoplasms

Original Publication Date
Article Source
External Web Content
Abstract Myeloproliferative neoplasms (MPNs) were previously thought to result solely from somatic mutations; however, familial clustering and germline genetic testing have revealed hereditary MPNs. These hereditary MPNs are one type of hereditary hematopoietic malignancy (HHM)…

Patient and Caregiver Involvement With Prior Authorization and Care Delivery and Delays

Original Publication Date
Article Source
External Web Content
Introduction Payers employ health care utilization–management strategies, including prior authorization (PA), to limit costs and promote evidence-based, guideline-concordant care. However, PA may be inconsistently applied and associated with patient confusion and frustration.1-3…

Adolescent and Young Adult versus Older Adult Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Center Experience from the MENA Region 

Original Publication Date
Article Source
External Web Content

Background: Philadelphia-negative myeloproliferative neoplasms (MPNs), including essential thrombocythaemia (ET), polycythaemia vera (PV), and myelofibrosis (MF), usually affect older adults, but a subset occurs in adolescents and young adults (AYA). Regional age-stratified data…

Insights to provider practice of germline testing for inherited hematologic malignancy predisposition syndromes to inform hematopoietic stem cell transplantation 

Original Publication Date
Article Source
External Web Content
Highlights -Considerable heterogeneity exists in germline testing implementation across hematopoietic stem cell transplantation centers in the United States. -Lack of standardized protocols affects the timing of testing and inconsistent sample collection workflows. -Barriers to…

The MDS Spectrum - Lower Risk MDS, Higher Risk MDS and MDS/MPN Overlap

Thumbnail for video Register Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Uma Borate, MBBS
Alice S. Mims, MD
During this webinar, Drs. Uma Borate and Alice Mims will discuss lower risk MDS, higher risk MDS and MDS/MPN overlap. They will explore key disease characteristics, current treatment approaches, and considerations for managing these complex myeloid neoplasms. After the…
Subscribe to Myeloproliferative Neoplasms (MPN)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.